Antihypertensive AgentsHypertensionAdrenergic beta-AntagonistsBlood PressureCalcium Channel BlockersAngiotensin-Converting Enzyme InhibitorsPressureBlood Pressure DeterminationBlood Pressure Monitoring, AmbulatoryMetoprololAtenololHeart RateMedication AdherencePropanolaminesBisoprololCeliprololMedication ErrorsDiureticsCarteololHospital PlanningHydrostatic PressureTime FactorsBetaxololSystoleTreatment OutcomeBlood Pressure MonitorsHemodynamicsPropranololTimololProspective StudiesRisk FactorsDouble-Blind MethodAngiotensin II Type 1 Receptor BlockersCarbazolesInterleukin-1betaDrug Therapy, CombinationDose-Response Relationship, DrugHeart FailureFollow-Up StudiesHydrochlorothiazideMedication SystemsLabetalolMedication ReconciliationDiastoleCardiovascular DiseasesIntraocular PressureHypotensionAcebutololMedication Systems, HospitalReninRats, Inbred SHRRetrospective StudiesIntracranial PressureArterial PressureVascular ResistancePulseCohort StudiesKidneyTransducers, Pressurebeta 2-MicroglobulinCross-Sectional StudiesAge FactorsRegression AnalysisElectrocardiographyMyocardial InfarctionRats, Sprague-DawleySympathetic Nervous SystemCircadian RhythmPindololSodium Chloride Symporter InhibitorsPatient CompliancePotassium Channel BlockersReceptors, Adrenergic, betaPractololUnited StatesCardiovascular SystemAdrenergic alpha-AntagonistsVenous PressureAnalysis of VarianceTetrazolesHypertension, RenalCoronary DiseaseRenin-Angiotensin SystemAngiotensin IIAtmospheric PressureSex FactorsChronic DiseaseDrug UtilizationAlprenololAir PressureSphygmomanometersSodium Chloride, DietaryRats, Inbred WKYRandomized Controlled Trials as TopicBaroreflexNorepinephrineClinical Trials as TopicBody WeightBody Mass IndexPractice Guidelines as Topic